Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
Crossref DOI link: https://doi.org/10.1007/s12325-019-00911-y
Published Online: 2019-03-06
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maltais, François
Hamilton, Alan
Voß, Florian
Maleki-Yazdi, M. Reza
Funding for this research was provided by:
Boehringer Ingelheim (N/A)
Text and Data Mining valid from 2019-03-06
Article History
Received: 26 October 2018
First Online: 6 March 2019